Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-20-038115
Filing Date
2020-02-14
Accepted
2020-02-14 16:00:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d891928dsc13g.htm SC 13G 44928
  Complete submission text file 0001193125-20-038115.txt   46276
Mailing Address C/O EIDOS THERAPEUTICS, INC. 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address
Kumar Neil (Filed by) CIK: 0001742485 (see all company filings)

Type: SC 13G

Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Subject) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91059 | Film No.: 20619096
SIC: 2834 Pharmaceutical Preparations